CClinicalTrials.gg
Active, not recruitingNCT03667664PREPAUpdated Sep 9, 2025

PREPA PREvention of Loss of Autonomy

An interventional study of Multidimensional assessments and Multicomponent group-based and supervised exercise program in Mobility Limitation and Physical Activity, sponsored by Hospices Civils de Lyon. Active, not recruiting at 1 site in France. Per ClinicalTrials.gov, last updated 2025-09-09.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
530
Allocation
Not applicable
Sex
All
01

Study summary

According to several reports, the proportion of people aged 80yrs or older will be doubled within the next 25y, reaching 10% of the global population. Furthermore, the health life expectancy at 65y is 10.4y which remains much lower than the general life expectancy. As a result, there is a constant need of developing preventive strategies through multimodal programs.

Among the predictive factors of mobility disability with age, muscular weakness and decreased physical function are major components. These two factors are known of being responsible for falls and fractures that lead to decrease the quality of life and an increase in mortality.

Exercise and nutrition are the only components that have proven their efficacy to struggle mobility disability risk. It is important to integrate these two components in a sustained intervention within a multidimensional prevention program. However, there is a lack of implementation of these programs in primary care.

Indeed, neither the screening of older adults at risk of mobility disability, nor the preventive actions are usually implemented for this population. The implementation of a prevention care pathway, with personalized intervention and a sustained follow-up, along with supervised exercise training combined with nutritional counselling, is the public health imperatives.

Based on prevention care pathway that designed for community-dwelling older adults screened at risk of mobility disability. The purpose of this open cohort study was to highlight the efficacy and the feasibility of a multimodal program implemented on real-life setting specifically on the physical function and risk of mobility loss, along with their maintenance at 6-months and 1-year follow-up.

02

Conditions studied

  • Mobility Limitation
  • Physical Activity

Keywords

  • Autonomy
  • Elderly
  • Physical exercise
  • Nutrition
  • Prevention
03

In context

Mobility Limitation

317 studies on the registry are indexed under Mobility Limitation; 97 are open to participants now.

This study's planned enrollment of 530 is above the median of 46 across 265 interventional studies indexed under Mobility Limitation.

Browse Mobility Limitation studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient eligible for the "mobility loss prevention" program
  • At least one of the following signs:

    • Difficulty carrying a loaded shopping basket (about 4.5 kg)
    • Difficulty rising from a chair without using the arms
    • Difficulty climbing one flight of stairs (10 steps)
    • Difficulty moving around
    • Slowed walking
    • Difficulty walking more than 400 meters without stopping
    • Walking time \< 30 minutes/day
    • Fatigue during mild physical efforts: running errands, household chores; fear of falling and/or at least one fall in the past year
    • Recent unintentional weight loss: weight loss ≥ 5% in 6 months or BMI \< 22 kg/m²

Exclusion criteria

Exclusion Criteria:

  • Patient who has not given consent to participate
  • Patient under guardianship in retrospective phase
  • Locomotor disability
  • expectancy of life being under 12 months
  • BMI ≥ 35 Kg/m2
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
530 participants (estimated)

Study arms

  • Other
    Multicomponent group-based supervised exercise program

    Community-dwelling older adults aged of \>70y, screened at risk of mobility disability risk factors and assessed with at least 1 mobility disability risk factor (see intervention 1). These subjects are included in the protocol and participate in a multicomponent exercise program.

    Diagnostic Test: Multidimensional assessments · Other: Multicomponent group-based and supervised exercise program · Other: Follow-up at T3 + 6 months and T3 + 12 months

Interventions

  • Diagnostic testMultidimensional assessments

    Evaluation carried out during a day hospital at T0 (initial assessment) and T3 following the exercise program including: 1. Clinical assessment by a geriatrician 2. Nutritional assessment 3. Physical capacity assessment Following initial assessment (T0), older adults are included in the multicomponent exercise program if they present mobility disability risk factors including : * At least pre-frailty regarding Fried frailty criteria AND/OR * At least probable sarcopenia regarding EWGSOP2 algorithm AND/OR * The presence of at least an intermediate fall risk AND/OR * The presence of a fear of falling Following the exercise program (T3), all participants are re-assessed in the same way as T0. Investigators then set goals in physical activity with participants to maintain benefits and foster self-engagement in an healthy lifestyle. Additionnally, participants are orientated to exercise facilities and received an individualized booklet of exercises for home-based training.

  • OtherMulticomponent group-based and supervised exercise program

    The intervention consists in a progressive multicomponent exercise training protocol. There are 2 sessions per week of 1 hour each for a total of 12 weeks. Sessions involve functional, resistance and balance exercises. Intensity is based on rating perceived effort (Borg's scale CR1-10) and volume towards 1 to 3 sets of 6 to 15 repetitions. Progressiveness in intensity and volume was based on effort tolerance, contraction regimen, velocity and load. Training schedule is described elsewhere (Delaire et al, 2023 ; doi.org/10.3390/nu15194100). Participants are allocated to an homogenous group based on functional status and cardiorespiratory comorbidities. Trained kinesiologists supervised the exercise program. Participants used free weights and elastic bands.

  • OtherFollow-up at T3 + 6 months and T3 + 12 months

    Follow-up at T3+6 months: Investigators interviewed participants for 30 minutes. During the interview, data collection include:record of undesirable events in the interval T3 / T3+6 (falls, unscheduled hospitalization, illness, institutionalization), medication changes, ADL, IADL, FES-I, and RAPA. Goal-settings at T3 are adjusted if not reach. Finally, investigators stimulate intrinsic motivation for PA. Follow-up at T3 + 12 months: Investigators re-assessed physical capacity, physical activity level, quality of life, fall risk and frailty for the last visit. Data collection include: * SPPB * Handgrip test and maximal isometric strength of the quadriceps * Questionnaires : SarQoL©, FES-I, RAPA * Gait quality analysis using inertial sensors * Undesirable events in the interval T3+6 / T3+12 (falls, unscheduled hospitalization, illness, institutionalization) * Medication changes * Body mass index * ADL and IADL At last, goals in physical activity are adjusted if they are still not reach

06

What researchers measure

Primary outcomes

  1. Functional status

    Functional status is assessed using the overall SPPB (Short Physical Performance Battery) score based on three components: 6 meters usual walking speed, 5 repetitions chair stand test, and static balance tests. (composite score /12). The SPPB score is calculate from the results in 3 subtests. It ranges from 1 to 12 points. Clinically meaningful change is 1 point.

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

Secondary outcomes

  1. Evaluation of effectiveness on muscle strength : Handgrip test (kg)

    The subject has to perform 3 maximum isometric contractions on a dynamometer which records the force developed. The average of these 3 values will be retained. A value lower than \<16kg for women and \<27kg for men are considered abnormal and indicate the presence of probable sarcopenia.

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  2. Evaluation of effectiveness on muscle strength : Maximal isometric strength of the quadriceps (kg)

    The subject has to perform 3 maximum isometric muscular contractions separately against a dynamometer. The best performance (i.e. greatest strength measure) is collected.

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  3. Evaluation of effectiveness on functional status : 5 repetitions chair stand test (s)

    The subject has to stand with knee extended and sit from a chair 5 times without stopping

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  4. Evaluation of effectiveness on functional status : Time in TUG (s)

    The subject must get up from a chair, walk at usual speed 3 meters, turn around, and sit down again. A value greater than or equal to 20 seconds will be considered abnormal.

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  5. Evaluation of effectiveness on functional status : Lower body muscle power measured by a one sit-to-stand test perform at maximum speed (Neurocom Balance Master, Medimex®, France)

    Estimation of lower limb muscle power based on the mean of the 3 repetitions of a sit-to-stand test perform separately. For each transfer, the lifting index (as a % of body weight), reaction time (s), the oscillation limit of the center of gravity, and the symmetry of the supports are measured

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  6. Evaluation of effectiveness on functional status : Gait quality analysis using inertial sensors (GaitUp, MindMaze®, Switzerland)

    A 50 meters walking test perform at usual speed is realized. Data collection include : gait speed, gait variability, gait asymmetry, % flight time, % support time, % double support time, angle of attack, push-off angle, step height, step length, number of cycles in the U-turn, angles in the U-turn

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  7. Evaluation of muscle mass : SMI measured by bio-impedance analysis (kg.m2)

    SMI is a relative index which is computed from the Sergi equation. Cut-off points are \<7,0 and \<5,5 for men and women respectively and are considered abnormal. These are the reference values for sarcopenia diagnosis.

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  8. Evaluation of muscle mass : Ultrasonography of the vastus lateralis

    Data collection of muscle density (cm)

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  9. Evaluation of muscle mass : Ultrasonography of the vastus lateralis

    Data collection include of pennation angle (degree)

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  10. Evaluation of muscle mass : Ultrasonography of the vastus lateralis

    Data collection include of fiber length (cm)

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  11. Evaluation of dependencies : Katz scale (Activities of Daily Living - ADL)

    Katz scale (ADL) consists of 6 questions. Score varies from 0 to 6. The lower the score, the more dependant is the patient

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  12. Evaluation of dependencies : Lawton scale (Instrumental Activities of Daily Living-IADL)

    Lawton scale (IADL) consists of 8 questions. Score varies from 0 to 8. The lower the score, the more dependant is the patient.

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  13. Record of undesirable events : Falls, unscheduled hospitalization, illness, institutionalization

    Data are collected between intervals : T3/T3+6 and T3+6/T3+12

    Time frame: initial assessment (baseline), following the exercise program (month 3), 6 months following the exercise program (month 9), last visit (month 15)

  14. Evaluation of fear of falling : FES-I questionnaire (/64)

    The validated French translated form is used. Questionnaire is self-administrated. FES-I questionnaire (Falls Efficacy Scale-International) consists of 16 questions. Score varies from 16 to 64. A fear of falling is considered to be present with score \>23.

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  15. Evolution of the level of physical activity : RAPA questionnaire (/10)

    The RAPA is validated physical activity questionnaire in older adults. The score is calculated from the reported information of each visit. Score varies from 0 to 10. The higher the score, the more physically active is the patient.

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  16. Evolution of quality of life : SarQoL© questionnaire

    The SarQoL© is a validated questionnaire in sarcopenic older adults. French validated translated form were used. The questionnaire is self-administrated. An overall change of 7,35 points in the questionnaire is considered to be clinically meaningful.

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  17. Evaluation of biomarkers : risk of fractures - Calcemia (mmol/L)

    initial assessment (baseline), following the exercise program (month 3)

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  18. Evaluation of biomarkers : risk of fractures - Vitamin D (nmol/L).

    initial assessment (baseline), following the exercise program (month 3)

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  19. Evaluation of biomarkers : exploratory Fibroblast Growth Factor 19 (FGF-19) (pg/L)

    FGF-19 is analysed in plasma samples by ELISA method. Blood sample is collected in routine care.

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  20. Evaluation of biomarkers : nutritional status - Albumin (g/L)

    Albumin (g/L)

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  21. Evaluation of biomarkers : nutritional status - Pre-albumin (g/L)

    Pre-albumin (g/L)

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  22. Evaluation of biomarkers : inflammation C-reactive protein

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  23. Evaluation of physical frailty : Fried criteria

    Fried criteria include : unvolontary weight loss \>5% during the last 12 months, self-reported exhaustion, low gait speed, low grip strength and poor physical activity level. 0 criterion = non frail ; 1-2 criteria = pre-frail ; ≥3 criteria = frail

    Time frame: initial assessment (baseline), following the exercise program (month 3), last visit (month 15)

  24. Evaluation of sarcopenia : EWGSOP2

    No sarcopenia = muscle strength and mass normal Probable sarcopenia = low muscle strength, normal muscle mass Sarcopenia = low muscle strength and mass Severe sarcopenia = low muscle strength and mass + poor physical performances

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  25. Evaluation of nutritional status : Mini Nutritional Assessment

    This self-administrated questionnaire consists of 18 questions. Score varies from 0 to 30. From 17 to 24 points : risk of malnutrition Less than 17 points : poor nutritional status

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  26. Evaluation of nutritional status : caloric (kcal) needs and intakes from the dietary survey

    Survey is self-administrated. Needs/Intake are calculated based on the survey.

    Time frame: initial assessment (baseline), following the exercise program (month 3)

  27. Evaluation of nutritional status : protein (g/J) needs and intakes from the dietary survey

    Survey is self-administrated. Needs/Intake are calculated based on the survey.

    Time frame: initial assessment (baseline), following the exercise program (month 3)

07

Study locations

1 site
  • Service de Médecine Gériatrique Groupement Hospitalier Sud
    Pierre-Bénite, 69495, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03667664
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Sep 12, 2018
Start date
Jul 10, 2018
Primary completion
Oct 2025 (estimated)
Completion
Oct 2025 (estimated)
Last update
Sep 9, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion